Nov 08 2024 This Week in Cardiology
This Week in Cardiology
Medscape Podcasts
4.9 • 963 Ratings
🗓️ 8 November 2024
⏱️ 32 minutes
🧾️ Download transcript
Summary
The EARLY TAVR trial, colchicine after MI, and the TRISCEND II trial of tricuspid valve replacement are the topics John Mandrola, MD, covers in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Early TAVR
- EARLY TAVR https://www.acc.org/latest-in-cardiology/clinical-trials/2024/10/24/14/42/early-tavr
- Rationale https://doi.org/10.1016/j.ahj.2023.11.019
- AVATAR https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057639
- RECOVERY https://www.nejm.org/doi/full/10.1056/NEJMoa1912846
- FAME 2 https://www.nejm.org/doi/full/10.1056/NEJMoa1205361
- Rajkumar; Faith Healing in Unblinded Trials https://pubmed.ncbi.nlm.nih.gov/29530888/
- PARTNER 3 trial https://www.nejm.org/doi/full/10.1056/NEJMoa2307447
- EARLY TAVR: A Positive Trial That Fails to Inform Clinical Decisions https://www.medscape.com/viewarticle/early-tavr-positive-trial-fails-inform-clinical-decisions-2024a1000kec
II. Colchicine
- Meta-analysis https://doi.org/10.1016/j.eclinm.2024.102835
- Clear-Synergy Rationale https://pubmed.ncbi.nlm.nih.gov/38936755/
- COLCOT (post MI) https://www.nejm.org/doi/full/10.1056/NEJMoa1912388
- LoDoCo (Chronic CAD) https://www.nejm.org/doi/full/10.1056/NEJMoa2021372
III. TRISCEND II Trial
- TRISCEND II Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2401918
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
Transcript
Click on a timestamp to play from that location
| 0:00.0 | You're listening to This Week in Cardiology from the heart.org, Medscape Cardiology. |
| 0:05.8 | This podcast is intended for healthcare professionals only. |
| 0:08.9 | Any views expressed are the presenters own and do not necessarily reflect the views of WebMD or Medscape. |
| 0:14.6 | You can now access the latest in medical news on your Amazon Alexa-enabled device. |
| 0:19.8 | Join me, Perry Wilson, every weekday morning for Medscape Medical Minute, where I highlight |
| 0:24.2 | the top medical stories of the day. |
| 0:26.4 | To add Medscape Medical Minute to your flash briefing, search for Medscape Medical Minute |
| 0:30.4 | on Amazon and click enable. |
| 0:32.4 | Or open the Amazon Alexa app, go to Skills, search for Medscape Medical Minute, and click |
| 0:37.4 | enable. |
| 0:38.3 | Then say, Alexa, what's the news? |
| 0:40.5 | Or Alexa, what's my flash briefing? |
| 0:43.1 | I hope you'll join us. |
| 0:44.5 | Hi, everyone. |
| 0:45.6 | This is John Mandrola from the heart.org medscape cardiology, and this is this week in |
| 0:51.1 | cardiology for November 8, 2024. |
| 0:55.9 | This week, I'll talk about the early tavern trial, |
| 0:59.4 | Culchicine after MI, and the tricent two trial of the trans catheter tricuspid valve replacement. |
| 1:07.9 | First, I want to say thank you to my Brazilian colleagues for the kind invitation to |
| 1:12.9 | the Brazilian EP meeting last weekend in Curitiba. I gave five talks, including the plenary |
| 1:19.0 | session on evidence-based medicine. It's my third time in Brazil, and I remain impressed regarding |
| 1:25.3 | the quality of the EP and critical appraisal in that country. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.